Retrospective Chart Review Study of Patients With PIK3CA-Related Overgrowth Spectrum Who Have Received Alpelisib
Clinical trial NCT04285723 · COMPLETED
Trial details
- NCT number
- NCT04285723
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2020-06-09
- Primary completion
- 2021-04-16
- Enrollment
- 57
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.